Our result not only helps us to better understand the regulatory potential of SNHG7 in pancreatic cancer stemness and Folfirinox resistance, but it is also important for identifying new pharmacological targets and devising innovative treatment techniques to overcome resistance. Here, SNHG7 is linked to familial pancreatic carcinoma.